Risultati per: Dalla presbifagia alla sarcopenia, il trattamento in medicina generale
Questo è quello che abbiamo trovato per te
Milano, apre il Centro di Medicina aerospaziale per le terapie avanzate
Frutto dell’accordo quadro tra l’Università di Milano, l’Aeronautica Militare e la Fondazione Ca’ Granda Ospedale Maggiore Policlinico, il Cemata si propone come esempio di think-tank civile-militare
Sa1164 PREVALENCE OF SARCOPENIA IN PATIENTS WITH ADVANCED INTESTINAL NEUROENDOCRINE TUMORS
993 IL-6 IS A CRUCIAL MEDIATOR IN THE DEVELOPMENT OF PANCREATIC CANCER-INDUCED SARCOPENIA
Sa1213 SARCOPENIA IN CHRONIC PANCREATITIS IS ASSOCIATED WITH AN ACTIVATION OF MEMBERS OF THE TGF-β SUPERFAMILY AND IS INDEPENDENT OF EXOCRINE PANCREATIC FUNCTION
Sa1562 PRESENCE OF SARCOPENIA AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF ADVANCED HEPATIC FIBROSIS
Tu1569 PREVALENCE OF SARCOPENIA AND ITS RELATED FACTORS AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
Tu1558 MODIFIED MELD 3.0 SARCOPENIA SCORES IMPROVE PREDICTIVE ACCURACY FOR OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL THERAPY.
Su1712 DIAGNOSING SARCOPENIA WITH AI-AIDED ULTRASOUND (DINOSAUR) – A VALIDATION STUDY
EP85 IMPACT OF SARCOPENIA ON POST-LIVER TRANSPLANT HOSPITALIZATION DURATION: INSIGHTS FROM A SOUTH ASIAN COHORT
1226 MANAGEMENT OF SARCOPENIA IN SURGICAL PATIENTS: A MODIFIED DELPHI CONSENSUS
685 THE EFFICACY OF 12-WEEK SUPERVISED HOME-BASED EXERCISE AND BRANCHED-CHAIN AMINO ACIDS SUPPLEMENTATION FOR TREATMENT OF SARCOPENIA IN CIRRHOTIC PATIENTS: A PROSPECTIVE PILOT STUDY.
Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis
Objectives
To determine the association of non-alcoholic fatty liver disease (NAFLD) with the incidence of sarcopenia.
Design
Systematic review and meta-analysis of observational clinical studies.
Setting and participants
Adults with NAFLD.
Methods
Databases such as PubMed, Embase, Cochrane and Web of Science were searched for eligible studies published from the inception of each database up to 4 April 2023. All cross-sectional studies on the association between NAFLD and sarcopenia were included in this study. The quality of the included studies and risk of bias was assessed using the Agency for Healthcare Research and Quality checklist. STATA V.15.1 software was used for statistical analysis.
Results
Of the 1524 retrieved articles, 24 were included in this review, involving 88 609 participants. Our findings showed that the prevalence of sarcopenia was higher in the NAFLD group than in the control group (pooled OR 1.74, 95% CI 1.39 to 2.17). In a subgroup analysis by region, patients with NAFLD showed an increased risk of sarcopenia (pooled OR 1.97, 95% CI 1.54 to 2.51) in the Asian group, whereas patients with NAFLD had no statistically significant association with the risk of sarcopenia in the American and European groups, with a pooled OR of 1.31 (95% CI 0.71 to 2.40) for the American group and a pooled OR of 0.99 (95% CI 0.21 to 4.69) for the European group. Similar results were observed in the sensitivity analysis, and no evidence of publication bias was observed.
Conclusions and implications
The current study indicated a significant positive correlation between NAFLD and sarcopenia, which may be affected by regional factors. This study provides the correlation basis for the relationship between NAFLD and sarcopenia and helps to find the quality strategy of sarcopenia targeting NAFLD.
Diagnosi e trattamento della vescica iperattiva idiopatica: linea guida
Identificazione della malattia renale cronica in Medicina Generale
Stop al numero chiuso a Medicina, adottato il testo base in Senato
Marti, ‘massima convergenza’ in Commissione Istruzione al Senato